Skip to main content

Advertisement

Table 9 Ferric reducing antioxidant power (FRAP) of eugenol derivatives

From: Lead optimization for promising monoamine oxidase inhibitor from eugenol for the treatment of neurological disorder: synthesis and in silico based study

Compound/sample IC50 (µg/mL)a Sr. no IC50 (µg/mL)a
5a 5.934 ± 0.053 13a 18.14 ± 0.001
5b 5.112 ± 0.009 13b 10.77 ± 0.026
7 9.142 ± 0.061 13c 14.63 ± 0.007
9a 7.234 ± 0.001 13d 12.45 ± 0.017
9b 9.912 ± 0.005 16 16.88 ± 0.099
11 9.126 ± 0.013 17 15.91 ± 0.003
Eugenol 10.627 ± 0.082 l-Ascorbic acid 8.112 ± 0.091
  1. aValue are expressed as mean ± SEM, n = 3